European buyers of bulk phosphatidylserine often approve a supplier on price, assay, MOQ, and sample COA without ever asking the question that sits underneath all of them: how is this powder actually made? The short answer is that commercial PS is generally produced by an enzymatic conversion route: a high-phosphatidylcholine lecithin base is treated with the amino acid L-serine in the presence of an enzyme, so that a phosphatidyl group is transferred onto L-serine to form phosphatidylserine. For European buyers, the practical consequence is that process review is a real supplier-qualification task: the quoted route should match the authorized process description, the specification should cover the right identity points, and the supplier should be able to show process evidence without revealing confidential commercial details.
That question matters because PS is not a single generic powder. It can be made from soy or sunflower lecithin, at different assay levels, and through process variants that affect specification, source identity, and the documents a buyer can later pass to a customer. This guide is written for importers, distributors, supplement manufacturers, private-label brands, procurement teams, and QA or formulation teams in Europe. It explains the enzymatic production route in plain terms, maps it to the EU authorized baseline, and gives a process-evidence checklist a buyer can use before quotation approval or first order. It is not medical advice, it does not make medical treatment claims, and it does not reveal or invent any supplier's confidential process parameters.
Where Nutranexa is mentioned, only verified site facts are used. The site describes its PS as produced from natural lecithin and L-serine through bio-enzymatic conversion, with a production campus, R&D cooperation, and PS specification and COA evidence available for buyer review. Those facts support a process discussion without pretending that any specific manufacturing parameter is public.
The Short Answer: What European Buyers Should Know First
If your team is reviewing bulk PS for a European supplement or food project, the minimum workable process understanding is:
- Bulk PS is made by enzymatic conversion, not by simple extraction from plants. The common route starts with lecithin rich in phosphatidylcholine (PC) and converts part of that PC into PS using the amino acid L-serine and an enzyme.
- The enzyme performs a transphosphatidylation reaction. Phospholipase D (PLD) is the enzyme family most commonly discussed for this reaction: it transfers the phosphatidyl group from a donor phospholipid to L-serine.
- The EU authorized this route for soya PS. Commission Implementing Decision 2011/513/EU describes the authorized ingredient as obtained through enzymatic transphosphatidylation of high-phosphatidylcholine soybean lecithin with L-serine.
- Specifications describe the outcome of the process. Moisture, phospholipid content, PS assay, free L-serine, glycerides, tocopherols, and phytosterols are the public specification points used to describe the authorized ingredient.
- Process evidence is a document-control task, not a trade-secret request. Buyers should ask for route confirmation, source identity, process-flow summary, batch documentation, COA linkage, and any market-specific files - without asking a supplier to reveal confidential process parameters.
That framing keeps the review practical. A buyer does not need to know the exact enzyme dosage or reaction temperature inside a competitor's plant. The buyer does need to know that the route is consistent, the source is controlled, the specification is complete, and the documents connect from raw material to drum.
How Bulk Phosphatidylserine Is Made: The Enzymatic Route
Lecithin and L-serine are the two building blocks
Phosphatidylserine is a phospholipid: a glycerophosphate skeleton with two fatty acids and L-serine attached through a phosphodiester linkage. That molecular structure is the reason the production route looks the way it does. Instead of isolating PS directly from plant tissue, commercial producers start with a lecithin base that is rich in phosphatidylcholine and use L-serine as the second building block.
The EU decision describes the ingredient's chemical identity in exactly these terms: PS consists of a glycerophosphate skeleton conjugated with two fatty acids and L-serine via a phosphodiester linkage. For a buyer, that sentence explains why source identity matters. Soy lecithin, sunflower lecithin, and other phospholipid bases have different fatty-acid and phospholipid profiles, so the PS produced from them is not identical in every specification point.
Transphosphatidylation converts PC into PS
The key reaction is called transphosphatidylation. In this reaction, an enzyme transfers a phosphatidyl group from a donor phospholipid - typically phosphatidylcholine from lecithin - to L-serine, forming phosphatidylserine. Phospholipase D is the enzyme family most commonly associated with this biocatalytic synthesis of PS from lecithin and L-serine.
Peer-reviewed work supports this description. A 2019 study in Bioprocess and Biosystems Engineering describes phospholipase D-mediated green synthesis of phosphatidylserine, with the enzyme expressed and evaluated in production hosts to improve transphosphatidylation activity. A 2023 study in Processes reports efficient biosynthesis of phosphatidylserine in a biphasic system through parameter optimization, again using the enzymatic route. Neither paper is about a specific commercial supplier; both confirm that the enzymatic route is the established scientific pathway for PS synthesis.
The commercial implication is straightforward: when a supplier says its PS is made from lecithin and L-serine through bio-enzymatic conversion, that description matches the well-documented enzymatic route. When a supplier cannot confirm the conversion step or the source base, the buyer should slow down and ask for the technical file.
Downstream purification, drying, and quality control
After the conversion reaction, the process continues through typical downstream steps:
| Process stage | What it normally involves | Buyer relevance |
|---|---|---|
| Reaction and conversion | Lecithin base reacts with L-serine in the presence of enzyme | Confirms the route and the two building blocks |
| Separación y purificación | Removing unreacted materials, enzyme residues, and by-products | Supports specification limits such as free L-serine and glycerides |
| Concentration and drying | Preparing a powder with controlled moisture | Moisture is a published specification point |
| Sieving and blending | Achieving the target powder profile and batch uniformity | Supports consistent assay and flow behavior |
| Control de calidad final y lanzamiento | Assay, moisture, peroxide value, insoluble matter, heavy metals, microbiology as applicable | Matches the COA and release documentation |
| Packaging and dispatch review | Drum, liner, labels, batch documents, and shipment checks | Connects the batch record to the drums received |
These stages are generic descriptions of how such ingredients are processed; they are not claims about any specific manufacturer's confidential parameters. The table is useful because it shows the buyer which specification points can be tied to which process stage. For example, a free L-serine limit relates to reaction completeness and purification, while a moisture limit relates to drying and packaging controls.
What the EU Authorisation Says About the Process
The authorized process definition
For European buyers, the most important regulatory anchor is Commission Implementing Decision 2011/513/EU, adopted on 19 August 2011, which authorized the placing on the market of "Phosphatidylserine from soya phospholipids" as a novel food ingredient under Regulation (EC) No 258/97. The Annex I specification states that the ingredient is obtained through enzymatic transphosphatidylation of high-phosphatidylcholine soybean lecithin with the amino acid L-serine, and that the designation on labelling is "Soya phosphatidylserine".
That sentence is the legal baseline for the soy route. Under the current novel-food framework, the authorized novel food is listed in the Union list established by Commission Implementing Regulation (EU) 2017/2470, which carries forward the earlier authorization with conditions of use, labelling requirements, and specifications. Buyers reviewing a soy PS quotation should confirm that the quoted route maps to this authorized description - the same logic a buyer would use in a novel-food review before approving a route for Europe.
Public specification points
The published specification for the authorized powder includes the following characteristics:
| Specification point | Published value |
|---|---|
| Humedad | Less than 2% |
| Phospholipids | Not less than 85% |
| Phosphatidylserine | Not less than 61% |
| Glycerides | Less than 2% |
| Free L-serine | Less than 1% |
| Tocopherols | Less than 0.3% |
| Phytosterols | Less than 0.2% |
The same decision also authorizes a liquid form containing medium-chain triacylglycerides (MCT) as a carrier, with lower PS content because of the added oil. These numbers are useful reference points, not a universal requirement for every commercial PS grade: suppliers commonly offer multiple assay grades, such as 20% and 50% PS, and buyers should compare the quoted specification against the intended application rather than assume one value fits all. For the EU regulatory file, the key point is that the route and identity match the authorized ingredient and its designation.
A Process-Evidence Checklist for Supplier Qualification
European buyers do not need a supplier's trade secrets to verify a PS manufacturing process. They need a controlled evidence file that answers six questions:
- Which route is quoted? Confirm general PS, soy PS, or sunflower PS, and confirm that the route is consistent from quotation to COA to label.
- What is the source base? Confirm the lecithin source and whether any source change would trigger re-review, using the same logic as a source-change review.
- What does the process description say? Ask for a process-flow summary that confirms enzymatic conversion without requiring confidential parameters.
- Does the specification cover identity and purity? Check PS assay, phospholipids, moisture, free L-serine, glycerides, tocopherols, phytosterols, and any application-specific items.
- Is the COA linked to the batch and the drum? The COA should connect to a specific lot and to the 25 kg drums received, matching the COA and specification review process.
- Are the supporting documents current and route-specific? Request specification version, COA sample, production-license evidence, source statements, and any market-specific files before approval.
For European projects, the buyer should also decide how the process file feeds the customer dossier. A distributor or brand that later supplies a European customer will be asked how the ingredient is made, whether it is the authorized soya route, and what documents support that statement. The distributor document pack y manufacturer audit reviews cover the surrounding file; this checklist focuses specifically on the process evidence itself.
How to Verify Process Claims Without Asking for Trade Secrets
Process verification works best when the buyer separates what must be documented from what is legitimately confidential:
- Require a route statement, not a recipe. "Soy lecithin and L-serine through bio-enzymatic conversion" is verifiable; a request for exact enzyme dosage and temperature is not reasonable.
- Use the specification as indirect process evidence. Limits for free L-serine, glycerides, moisture, and tocopherols reflect process design and control, so a complete specification is itself part of the process file.
- Check consistency across documents. The route name, source identity, specification version, COA lot, and drum labels should tell the same story.
- Ask what changed. If a supplier recently changed source, process, or specification, the buyer should see the change-control record rather than a silent update - the same discipline as a repeat-order document review.
- Confirm the batch record summary. Buyers can request a summary of batch records (raw material confirmation, reaction, purification, drying, QC, release) without receiving proprietary process data.
Red Flags and Hold Points
Slow the approval when the process file shows:
- A route statement that changes between quotation, sample COA, and bulk COA.
- A specification that omits identity points such as phospholipids, free L-serine, or glycerides, or that cannot be tied to the quoted grade.
- No process-flow summary, or a description that avoids the conversion step entirely.
- A COA that cannot be linked to a batch and to the drum set received.
- No evidence of source control for the lecithin base, or an unexplained source change.
- A "general PS" file offered for a soy-specific or sunflower-specific customer request.
- Confusing lab results with process evidence: a COA shows a batch outcome, but it does not by itself prove the route, the source, or the process controls.
Record the gap and the decision - approve, approve with conditions, hold, or reject - in the supplier file, and escalate to the annual supplier review cycle if needed.
How Verified Nutranexa Facts Fit This Review
Nutranexa is a functional food ingredient manufacturer focused on phosphatidylserine, soy PS, sunflower PS, and soluble soybean polysaccharide. The primary manufacturing entity, Shandong Baianrui Biopharmaceutical Co., Ltd., was founded in 2013 and operates a 110,000+ m2 production campus, with a primary export focus in Europe and North America. The site describes its PS as produced from natural lecithin and L-serine through bio-enzymatic conversion, and it lists PS production-license evidence and R&D cooperation with East China University of Science and Technology among its manufacturing facts.
For the process review, those verified facts support three practical points. First, the site's own description of bio-enzymatic conversion from lecithin and L-serine matches the enzymatic route described above, so a buyer can start from a consistent route statement. Second, Nutranexa publishes a PS specification and COA process: the product page shows sample COA availability for PS 20% sunflower and PS 50% grades and requests current specification confirmation before quotation, which is exactly the document discipline this guide recommends. Third, the manufacturing page presents a public process outline - raw material confirmation, bio-enzymatic conversion, separation and purification, drying, sieving, and blending, final QC and release, and packaging and shipment review - without exposing confidential parameters.
For PS, the published commercial baseline is a 25 kg MOQ with 25 kg net per drum, and the site directs buyers to request current specifications, COA samples, certificate files, and packaging and shipment details from the sales team. Buyers should still complete their own process-evidence review for the exact quoted route, source, grade, and destination market. Nothing on this page claims that any Nutranexa document proves a specific process parameter, and buyers should request current files for the exact product configuration rather than assume one document covers every grade.
If your team is in the middle of qualifying a PS route for Europe and needs the current specification, COA samples, and manufacturing context to complete a process-evidence file, contact Nutranexa with your target grade, source preference, and destination market so the review starts from the exact quoted configuration.
Preguntas frecuentes
How is bulk phosphatidylserine manufactured?
Bulk phosphatidylserine is generally produced by enzymatic conversion: a lecithin base rich in phosphatidylcholine is reacted with the amino acid L-serine in the presence of an enzyme, so that phosphatidyl groups are transferred onto L-serine to form PS. The resulting material is purified, dried, sieved, blended, quality-controlled, and packaged into drums.
What is the enzymatic transphosphatidylation process for PS?
Transphosphatidylation is the reaction in which an enzyme transfers a phosphatidyl group from a donor phospholipid - typically phosphatidylcholine from lecithin - to L-serine, forming phosphatidylserine. Phospholipase D is the enzyme family most commonly discussed for this biocatalytic synthesis.
Which process does the EU authorize for soya phosphatidylserine?
Commission Implementing Decision 2011/513/EU authorized "Phosphatidylserine from soya phospholipids" as a novel food ingredient and describes it as obtained through enzymatic transphosphatidylation of high-phosphatidylcholine soybean lecithin with L-serine, with the labelling designation "Soya phosphatidylserine". The authorization is carried forward in the Union list under Regulation (EU) 2017/2470.
What process evidence should European buyers request from a PS supplier?
Buyers should request a route statement, source identity, a process-flow summary, the current specification, a lot-linked COA, a batch-record summary, production-license evidence, and any market-specific files - without asking for confidential process parameters such as enzyme dosage or reaction conditions.
Is phosphatidylserine produced from lecithin and L-serine?
Yes for the common commercial route. The EU authorized soya PS as obtained from high-phosphatidylcholine soybean lecithin and L-serine through enzymatic transphosphatidylation, and peer-reviewed studies describe the same enzymatic synthesis of PS from lecithin and L-serine.
Conclusion
Phosphatidylserine manufacturing is not a black box that buyers must accept on trust. The enzymatic route - lecithin and L-serine converted by transphosphatidylation, then purified, dried, controlled, and packaged - is well documented in the EU authorization and in peer-reviewed science, and it can be reviewed at the document level without touching trade secrets. European buyers should confirm the quoted route, check the specification against the published identity points, tie the COA to the batch and the drum, and keep the process file consistent from quotation to delivery. That turns "how is PS made?" from a science question into a practical supplier-qualification checklist.
Fuentes
- EUR-Lex: Commission Implementing Decision 2011/513/EU (CELEX 32011D0513)
- EUR-Lex: Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods (CELEX 32017R2470)
- European Commission: Union list of novel foods
- Hou et al., "Phospholipase D engineering for improving the biocatalytic synthesis of phosphatidylserine", Bioprocess and Biosystems Engineering (2019)
- Guo et al., "Efficient Biosynthesis of Phosphatidylserine in a Biphasic System through Parameter Optimization", Processes (2023)
Contactar con Ventas
Contact Nutranexa to request current PS specifications, COA samples, production-license evidence, factory and dispatch imagery, and the exact 25 kg drum configuration for the soy or sunflower route you are evaluating for Europe. Share your target grade, source preference, destination market, and annual volume so the sales team can confirm the current technical file for your process-evidence review.
Próximos pasos recomendados
- Revisa el Phosphatidylserine página del producto.
- Comparar Soy PS y Sunflower PS.
- Verificar prueba de fabricación y Calidad e I+D.
Comuníquese con ventas para obtener documentos de productos
Comparta preferencia de fuente, aplicación, país y cantidad anual.
Contactar con Ventas
